Overview
Natasa Bratina practices in Ljubljana, Slovenia. Ms. Bratina is rated as an Experienced expert by MediFind in the treatment of Familial Hypercholesterolemia. Her top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, Reye Syndrome, and Newborn Low Blood Sugar.
Her clinical research consists of co-authoring 83 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Familial Hypercholesterolemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Type 1 Diabetes (T1D)Ms. Bratina isElite. Learn about Type 1 Diabetes (T1D).
- Distinguished
- Low Blood SugarMs. Bratina isDistinguished. Learn about Low Blood Sugar.
- Advanced
- Reye SyndromeMs. Bratina isAdvanced. Learn about Reye Syndrome.
- Experienced
- Celiac DiseaseMs. Bratina isExperienced. Learn about Celiac Disease.
- Congenital HyperinsulinismMs. Bratina isExperienced. Learn about Congenital Hyperinsulinism.
- Diabetic KetoacidosisMs. Bratina isExperienced. Learn about Diabetic Ketoacidosis.
- Familial HypercholesterolemiaMs. Bratina isExperienced. Learn about Familial Hypercholesterolemia.
- High CholesterolMs. Bratina isExperienced. Learn about High Cholesterol.
- MalabsorptionMs. Bratina isExperienced. Learn about Malabsorption.